Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
When I began Ozempic, in April 2023, I was in the doldrums of perimenopause, with high cholesterol, prediabetic blood sugar ...